ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.680,20
-0,25%
S&P 500
5.297,45
-0,45%
Dow Jones
39.644,42
-0,57%
Euro vs US Dollar
1,08224
-0,30%
Bitcoin
69.605,94
-0,75%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) News

STIM

Neuronetics (STIM)

Neuronetics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:STIM
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202413h32GlobeNewswire Inc.Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
07/05/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
07/05/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
07/05/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
07/05/202413h30GlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
03/05/202422h30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
01/05/202414h31GlobeNewswire Inc.NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthNASDAQ:STIMNeuronetics Inc
23/04/202422h30GlobeNewswire Inc.Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
10/04/202414h31GlobeNewswire Inc.New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalNASDAQ:STIMNeuronetics Inc
27/03/202421h30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
25/03/202413h30GlobeNewswire Inc.NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
07/03/202414h22GlobeNewswire Inc.Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkNASDAQ:STIMNeuronetics Inc
06/03/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/03/202413h30GlobeNewswire Inc.Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
01/03/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
01/03/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202422h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
28/02/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
28/02/202422h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
28/02/202422h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
27/02/202423h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
26/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
26/02/202422h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
23/02/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
22/02/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
22/02/202422h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
20/02/202421h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
 Showing the most relevant articles for your search:NASDAQ:STIM

Kürzlich von Ihnen besucht

ASE
PVMEZZ
Phoenix Vega Mezz
COIN
ABSTBTC
Abitshadow Token
EU
Q431S
Q431S
NASDAQ
VCLT
Vanguard Long Term Corpo...
BOV
PORD11
Polo Credito Imobiliario...
BIT
UB2AZH
UniCredit Bank
LSE
63UK
Aviva Nts
EU
0004N
Natixis SA null
LSE
UB0F
Ubsetf Ubof
NASDAQ
GRTX
Galera Therapeutics
TSXV
PORE
PowerOre
COIN
CMTRBTC
LATK
OUCHIUSDT
OUCHI Token
NYSE
INCM
Franklin Templet
DGFX
PLCUCUSDT
PLC Ultima
CRTO
RARIUSDT
Rarible
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten